InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Mahadevia Ankit, Chairman & CEO. Insider active across 1 company, notably Spero Therapeutics, Inc.. In total, 13 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €140k. History available since 26 August 2021. The latest transaction was disclosed on 28 August 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mahadevia Ankit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
6,572 shares@ US$1.976.1% of flowCommon StockSEC:0000950170-25-112661:0
20,000 shares0Common StockSEC:0000950170-25-087021:0
13,959 shares@ US$0.784.9% of flowCommon StockSEC:0000950170-25-014849:0
5,912 shares@ US$1.353.4% of flowCommon StockSEC:0000950170-24-102000:0
20,000 shares0Common StockSEC:0000950170-24-066625:0
63,795 shares@ US$1.3737.9% of flowCommon StockSEC:0000950170-24-011496:0
20,000 shares0Common StockSEC:0000950170-23-052692:0
9,040 shares@ US$1.265.0% of flowCommon StockSEC:0000950170-23-045442:0
12,286 shares@ US$1.819.6% of flowCommon StockSEC:0000899243-23-004039:0
531,914 shares0Common StockSEC:0000899243-23-003939:0
134,168 shares0Common StockSEC:0000899243-22-004591:0
8,000 shares@ US$5.9022.9% of flowCommon StockSEC:0000899243-21-050049:0
78,219 shares0Common StockSEC:0000899243-21-034502:0
13 of 13 declarations
About Mahadevia Ankit
Mahadevia Ankit is President and Chief Executive Officer. He has 13 filings in total. Across the 13 filings reviewed, the most recent activity, between 2021-08-30 and 2025-09-03, shows EUR 0 of purchases and EUR 140003 of sales, with Cession as the modal transaction nature. He is also a director of Spero Therapeutics, Inc. (XNAS).
